
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cancer-Associated Fibroblasts: Mechanisms of Tumor Progression and Novel Therapeutic Targets
Ralf‐Peter Czekay, Dong‐Joo Cheon, Rohan Samarakoon, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1231-1231
Open Access | Times Cited: 79
Ralf‐Peter Czekay, Dong‐Joo Cheon, Rohan Samarakoon, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1231-1231
Open Access | Times Cited: 79
Showing 1-25 of 79 citing articles:
Metastasis and MAPK Pathways
Mateusz Kciuk, Adrianna Gielecińska, Adrianna Budzinska, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3847-3847
Open Access | Times Cited: 99
Mateusz Kciuk, Adrianna Gielecińska, Adrianna Budzinska, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3847-3847
Open Access | Times Cited: 99
Cancer-associated fibroblasts: The chief architect in the tumor microenvironment
Mrinmoy Sarkar, Tristan Nguyen, Esheksha Gundre, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 68
Mrinmoy Sarkar, Tristan Nguyen, Esheksha Gundre, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 68
Advances of Wnt Signalling Pathway in Colorectal Cancer
Yaoyao Zhu, Xia Li
Cells (2023) Vol. 12, Iss. 3, pp. 447-447
Open Access | Times Cited: 54
Yaoyao Zhu, Xia Li
Cells (2023) Vol. 12, Iss. 3, pp. 447-447
Open Access | Times Cited: 54
Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects
Zhipeng Cao, Sadia Quazi, Sakshi Arora, et al.
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access | Times Cited: 7
Zhipeng Cao, Sadia Quazi, Sakshi Arora, et al.
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access | Times Cited: 7
Advanced Biomaterials and Biomedical Devices for Studying Tumor-Associated Fibroblasts: Current Trends, Innovations, and Future Prospects
Noura A. A. Ebrahim, Soliman M. A. Soliman
Deleted Journal (2025)
Closed Access | Times Cited: 2
Noura A. A. Ebrahim, Soliman M. A. Soliman
Deleted Journal (2025)
Closed Access | Times Cited: 2
Exosomal cargos-mediated metabolic reprogramming in tumor microenvironment
Shiming Tan, Yiqing Yang, Wenjuan Yang, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 40
Shiming Tan, Yiqing Yang, Wenjuan Yang, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 40
The tumor microenvironment: shaping cancer progression and treatment response
Sharav Desai, Vipul P. Patel, Kunal Bhosle, et al.
Journal of Chemotherapy (2024), pp. 1-30
Closed Access | Times Cited: 13
Sharav Desai, Vipul P. Patel, Kunal Bhosle, et al.
Journal of Chemotherapy (2024), pp. 1-30
Closed Access | Times Cited: 13
Radiomolecular Theranostics With Fibroblast-Activation-Protein Inhibitors and Peptides
Richard P. Baum, Emil Novruzov, Tianzhi Zhao, et al.
Seminars in Nuclear Medicine (2024) Vol. 54, Iss. 4, pp. 537-556
Closed Access | Times Cited: 10
Richard P. Baum, Emil Novruzov, Tianzhi Zhao, et al.
Seminars in Nuclear Medicine (2024) Vol. 54, Iss. 4, pp. 537-556
Closed Access | Times Cited: 10
Glycolysis reprogramming in CAFs promotes oxaliplatin resistance in pancreatic cancer through circABCC4 mediated PKM2 nuclear translocation
Rihua He, Chonghui Hu, Yuan Yuan, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Rihua He, Chonghui Hu, Yuan Yuan, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Unveiling the Immune Microenvironment’s Role in Breast Cancer: A Glimpse into Promising Frontiers
Amalia Kotsifaki, Nektarios Alevizopoulos, Vassiliki Dimopoulou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15332-15332
Open Access | Times Cited: 22
Amalia Kotsifaki, Nektarios Alevizopoulos, Vassiliki Dimopoulou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15332-15332
Open Access | Times Cited: 22
Mutant P53 in the formation and progression of the tumor microenvironment: Friend or foe
Elmira Roshani Asl, Davoud Rostamzadeh, Pascal H. G. Duijf, et al.
Life Sciences (2023) Vol. 315, pp. 121361-121361
Closed Access | Times Cited: 19
Elmira Roshani Asl, Davoud Rostamzadeh, Pascal H. G. Duijf, et al.
Life Sciences (2023) Vol. 315, pp. 121361-121361
Closed Access | Times Cited: 19
Gelatin methacryloyl and Laponite bioink for 3D bioprinted organotypic tumor modeling
Natan Roberto de Barros, Alejandro Palomar Gómez, Menekşe Ermis, et al.
Biofabrication (2023) Vol. 15, Iss. 4, pp. 045005-045005
Open Access | Times Cited: 17
Natan Roberto de Barros, Alejandro Palomar Gómez, Menekşe Ermis, et al.
Biofabrication (2023) Vol. 15, Iss. 4, pp. 045005-045005
Open Access | Times Cited: 17
Cancer therapy resistance mediated by cancer-associated fibroblast-derived extracellular vesicles: biological mechanisms to clinical significance and implications
Zhengjun Lin, Guoqing Li, Ke Jiang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Zhengjun Lin, Guoqing Li, Ke Jiang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Tumor hypoxia unveiled: insights into microenvironment, detection tools and emerging therapies
Joanna Ciepła, Ryszard Smolarczyk
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 8
Joanna Ciepła, Ryszard Smolarczyk
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 8
SERPINE1: Role in Cholangiocarcinoma Progression and a Therapeutic Target in the Desmoplastic Microenvironment
Ralf‐Peter Czekay, Craig E. Higgins, Hasan Basri Aydin, et al.
Cells (2024) Vol. 13, Iss. 10, pp. 796-796
Open Access | Times Cited: 6
Ralf‐Peter Czekay, Craig E. Higgins, Hasan Basri Aydin, et al.
Cells (2024) Vol. 13, Iss. 10, pp. 796-796
Open Access | Times Cited: 6
Immunomodulatory Properties of Immune Checkpoint Inhibitors—More than Boosting T-Cell Responses?
Michael Kuske, Maximilian Haist, T. Jung, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1710-1710
Open Access | Times Cited: 24
Michael Kuske, Maximilian Haist, T. Jung, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1710-1710
Open Access | Times Cited: 24
On-chip modeling of tumor evolution: Advances, challenges and opportunities
Chengpan Li, Joseph Benjamin Holman, Zhengdi Shi, et al.
Materials Today Bio (2023) Vol. 21, pp. 100724-100724
Open Access | Times Cited: 15
Chengpan Li, Joseph Benjamin Holman, Zhengdi Shi, et al.
Materials Today Bio (2023) Vol. 21, pp. 100724-100724
Open Access | Times Cited: 15
Immunotheranostic target modules for imaging and navigation of UniCAR T-cells to strike FAP-expressing cells and the tumor microenvironment
Liliana R. Loureiro, Lydia Hoffmann, Christin Neuber, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 13
Liliana R. Loureiro, Lydia Hoffmann, Christin Neuber, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 13
Advancements in Preclinical Models of Pancreatic Cancer
P Salu, Katie M. Reindl
Pancreas (2024) Vol. 53, Iss. 2, pp. e205-e220
Closed Access | Times Cited: 5
P Salu, Katie M. Reindl
Pancreas (2024) Vol. 53, Iss. 2, pp. e205-e220
Closed Access | Times Cited: 5
Clinical diagnosis and management of pancreatic cancer: Markers, molecular mechanisms, and treatment options
Chunye Zhang, Shuai Liu, Ming Yang
World Journal of Gastroenterology (2022) Vol. 28, Iss. 48, pp. 6827-6845
Open Access | Times Cited: 20
Chunye Zhang, Shuai Liu, Ming Yang
World Journal of Gastroenterology (2022) Vol. 28, Iss. 48, pp. 6827-6845
Open Access | Times Cited: 20
Identification of the diagnostic genes and immune cell infiltration characteristics of gastric cancer using bioinformatics analysis and machine learning
Rongjun Xie, Longfei Liu, Xianzhou Lu, et al.
Frontiers in Genetics (2023) Vol. 13
Open Access | Times Cited: 11
Rongjun Xie, Longfei Liu, Xianzhou Lu, et al.
Frontiers in Genetics (2023) Vol. 13
Open Access | Times Cited: 11
PDPN/CCL2/STAT3 feedback loop alter CAF heterogeneity to promote angiogenesis in colorectal cancer
Die Yu, Hanzheng Xu, Jinzhe Zhou, et al.
Angiogenesis (2024) Vol. 27, Iss. 4, pp. 809-825
Closed Access | Times Cited: 4
Die Yu, Hanzheng Xu, Jinzhe Zhou, et al.
Angiogenesis (2024) Vol. 27, Iss. 4, pp. 809-825
Closed Access | Times Cited: 4
TGF-β signaling orchestrates cancer-associated fibroblasts in the tumor microenvironment of human hepatocellular carcinoma: unveiling insights and clinical significance
Junwei Ge, Hongwei� Jiang, Junjun Chen, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Junwei Ge, Hongwei� Jiang, Junjun Chen, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
How modulation of the tumor microenvironment drives cancer immune escape dynamics
Pujan Shrestha, Zahra S. Ghoreyshi, Jason T. George
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Pujan Shrestha, Zahra S. Ghoreyshi, Jason T. George
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Nano-drug delivery strategies affecting cancer-associated fibroblasts to reduce tumor metastasis
Linghui Zou, Peng Xian, Qing Pu, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Linghui Zou, Peng Xian, Qing Pu, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access